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Purpose: The effects of leptin on female sexual behaviors are controversial, and stud-
ies on this topic are limited. The objectives of this study were to evaluate the direct ef-
fects of leptin on clitoral vasoreactivity in vitro and to determine the mechanism of 
action. 
Materials and Methods: Isometric tension studies were conducted to determine the ef-
fects of pretreatment with leptin (10
−8 M) on the contractile responses of rabbit clitoral 
corpus cavernosal smooth muscle strips. The effects of leptin were assessed on precon-
traction induced by phenylephrine (PE; 10
−9-10
−4M) and KCl (35-140 mM). We also 





−6 M), and sodium nitroprusside (10
−9-10
−4 M) in PE-precon-
tracted (10
−5 M) strips. 
Results:  Leptin enhanced ACh-induced relaxation in PE-precontracted strips. 
L-NAME pretreatment significantly reduced the effect of leptin on ACh-induced relax-
ation, whereas L-arginine potentiated the effect of leptin. Leptin decreased the KCl-in-
duced contractile responses. Leptin increased verapamil-induced relaxation responses. 
The relaxation effects of leptin on KCl-induced contraction were inhibited by 10
−5 M 
methylene blue and L-NAME pretreatment. 
Conclusions: A high concentration of leptin enhances ACh-dependent relaxation in clit-
oral cavernosal smooth muscles. These relaxation effects of leptin may occur through 
an NO-dependent mechanism and voltage-dependent calcium channel blockade. 
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INTRODUCTION
Leptin, an adipocyte-derived hormone, is known to modu-
late body weight by regulating food intake and energy ex-
penditure [1]. Apart from its previously envisaged function 
as an adipostatin, leptin has been shown to participate in 
a wide range of biological functions, including the sup-
pression of vascular smooth muscle proliferation and in-
duction of vasodilation [2,3]. Nitric oxide (NO) is the key 
molecule for the depressor response induced by leptin. 
Leptin acts on the endothelium by inducing the synthesis 
of NO via the activation of endothelial NO synthase (NOS), 
thereby evoking an endothelium-dependent vasodilation 
[1]. In contrast, leptin also secretes vasoconstrictive factors 
in human umbilical veins and the endothelium [4]. Longi-
tudinal and cross-sectional studies have shown an associa-
tion between serum leptin concentrations and various car-
diovascular risks including stroke [5], chronic heart failure 
[6,7], acute myocardial infarction [5], coronary heart dis-
ease [8], and left cardiac hypertrophy [9]. Thus, leptin 
seems to exert contradictory effects on cardiovascular 
pathophysiology.
    Leptin is thought to play important roles in pubertal de-
velopment and reproduction in females. Low plasma leptin 
levels in females with anorexia nervosa have been asso-
ciated with decreased sexual behaviors. An animal study Korean J Urol 2011;52:136-141
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showed that leptin administration reverses this reduction 
in sexual activity [10]. That study focused on the role of the 
central nervous system, and the underlying biological proc-
esses in humans have not yet been investigated. 
    In contrast with the study mentioned above, centrally 
administered leptin did not stimulate sexual behaviors in 
lean and obese Zucker female rats [11]. Thus, the effects 
of leptin on female sexual behaviors are controversial, and 
to date, few studies have addressed this issue. The effect 
of leptin on sexual desire, motivation, and genital arousal 
is still under debate, especially in terms of direct effects on 
clitoral hemodynamics. 
    The clitoris is an important component of female sexual 
response. It is highly vascular, and increased blood flow 
during sexual arousal results in clitoral erection [12]. 
Clitoral smooth muscle tone appears to regulate the 
changes in clitoral hemodynamics and genital arousal [13]. 
Therefore, evaluating the effects of a drug on clitoral 
smooth muscle tone may be a useful method for assessing 
changes in female sexual function. The objectives of this 
study were to evaluate the direct effect of leptin on clitoral 




With approval from the Ethics Committee for the Protec-
tion of Persons and Animals in Biochemical Research at the 
Institute of Medical Science of Chung-Ang University 
(Seoul, Korea), 30 New Zealand white female rabbits (2.5-3 
kg) were anesthetized with ether and killed by rapid 
exsanguination. The clitoris was removed and the cav-
ernosal tissues were excised and dissected from the tunica 
albuginea and surrounding connective tissue in a 100% 
O2-saturated physiologic solution. The cavernosal tissues 
were dissected in 2 strip preparations, each measuring ap-
proximately 2x2x6 mm. Sixty strips were prepared. To re-
cord isometric tension, the strips were placed in a 20 ml or-
gan bath containing bicarbonate-buffered physiologic salt 
solution (116 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM 
MgCl2, 24 mM NaHCO3, and 11 mM glucose) and con-
tinuously bubbled with a mixture of 95% O2 and 5% CO2 
at 37
oC. The strips were then attached by a silk tie to a force 
transducer (Harvard, Edenbridge, UK). The signals from 
this were recorded on a computer (IBM-PC, Pentium 4) 
with the use of a digital-analog signal converter and ampli-
fier (ADInstruments, Sydney, Australia). The organ cham-
ber was maintained at 37
oC (pH 7.4). The strips were main-
tained at 2 g of resting tension and were equilibrated for 
120 min with several changes of physiologic salt solution 
to avoid the accumulation of metabolites resulting from 
surgical injury.
2. Evaluation of tissue status
After resting, the basal tension of each strip was adjusted 
to the optimal isometric tension at which contraction with 
10
−5 M phenylephrine (PE; a selective alpha 1 agonist) 
treatment was maximal. After the maximal contractile re-
sponse to PE (10
−5 M) had been achieved, the optimal 
length of contraction by PE was regarded as the length 
maintained for 30 minutes at ＞90% basal contractile 
tension. After contraction, the relaxation responses in-
duced by 10
−5 M acetylcholine (ACh; endothelium-depend-
ent vasodilator) were checked. The strips that did not show 
optimal contraction and relaxation were excluded. With 
each pharmacologic agent, pretreatment was done over a 
20-min time period. In these studies, 90 strips were ob-
tained from 45 rabbits and 76 strips with an optimal length 
were used. At ＜50% of basal tension, the strips were re-
garded as damaged tissues and the experiments were 
completed. The results of the contraction and relaxation re-
sponses are expressed as a percentage.
3. Vasomotor responses of the strips
    1) Contractile and relaxation responses of the strips: To 
evaluate the effect of leptin on PE-induced contraction, 
concentration response curves were determined by adding 
successive logarithmic increments of PE (10
−9-10
−4 M) to 
the strips in the organ bath after they had been pretreated 
with 10
−8 M leptin.
    To evaluate the effect of leptin on ACh-induced relaxa-
tion, concentration response curves were determined by 
adding successive logarithmic increments of the endothe-
lium-dependent vasodilator ACh (10
−9-10
−4 M) to the 
strips in the organ bath after they had been pretreated with 
10
−8 M leptin. The results of the relaxation responses are 
expressed as the percentage relaxation of the contraction 
that was induced by PE (10
−5 M).
    2) Mechanism of the relaxation response for leptin: To 
analyze the mechanism involved in the responses induced 
by pretreatment with 10
−8 M leptin, the effects of leptin 
were assessed on contraction induced by KCl (a voltage- de-
pendent calcium channel activator, 35-140 mM). The re-
laxation of PE-precontracted strips induced by verapamil 
(a voltage-dependent calcium channel blocker, 10
−10- 10
−6 M) 
and sodium nitroprusside (an endothelium-independent 
vasodilator, SNP; 10
−9-10
−4 M) was also assessed. 
    To determine the relationship between the NO pathway 
and the effect of leptin, strips were pretreated with N(w)- 
nitro-L-arginine methyl ester (L-NAME; a nonspecific NO 
synthetic inhibitor, 10
−5 M) and L-arginine (an NO donor, 
0.1 mM) with and without leptin pretreatment (10
−8 M), 
and the effects of ACh (10
−9-10
−4 M) were observed in the 
PE-induced precontracted strips. 
    In addition, the effects of 1 mM and 10 mM tetraethyl 
ammonium (TEA; a nonspecific K
＋ channel blocker), gli-
benclamide (an ATP-sensitive K
＋ channel blocker, 10
−5 
M), indomethacin (a nonselective cyclooxygenase in-
hibitor, 10
−5 M), and 4-aminopyridine (4-AP; a volt-
age-dependent K
＋ channel inhibitor, 10
−5  M) on the en-
hancing effect of ACh-induced relaxation were verified. 
The effects of L-NAME (10
−5  M) and methylene blue (a se-
lective inhibitor of guanylyl cyclase inhibitor, 10
−5  M) pre-Korean J Urol 2011;52:136-141
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FIG. 1. Concentration-response curves for the effect of leptin 
pretreatment on contraction in rabbit clitoral corpus cavernosal 
strips in a phenylephrine dose-dependent manner (n=8).
FIG. 2. Concentration-response curves for the effect of leptin pre-
treatment on relaxation in rabbit clitoral corpus cavernosal strips 
in an acetylcholine dose-dependent manner. The preparation was 
preconstricted with 10
−5 M PE. n=12; 
a: p＜0.05.
FIG. 4. Concentration-response curves for the effect of leptin 
pretreatment on verapamil responses in rabbit clitoral corpus 
cavernosal strips. The preparation was preconstricted with 10
−5
M PE. n=12; 
a: p＜0.05.
FIG. 3. Concentration-response curves for the effect of leptin 
pretreatment of rabbit clitoral corpus cavernosal strips in 
high-concentration K solution. n=8; 
a: p＜0.05.
treatment on contraction induced by 70 mM KCl solution 




4. Solutions and reagents
All chemicals were purchased from Sigma Chemical Co. 
(St. Louis, MO, USA).
5. Statistical analysis
The results were obtained after more than 5 replicates of 
the experiments, and representative data are described. 
Results are expressed as the mean±standard error. Stati-
stical analysis of the data was performed by Student’s t-test 
and ANOVA. A p-value＜0.05 was considered significant.
RESULTS
1. Contractile and relaxation responses of the strips 
The strips were pretreated with 10
−8 M leptin and then ad-
ministered PE (10
−9-10
−4 M) in the organ bath. No change 
in contractile responses was observed (n=8) (Fig. 1). The 
strips were pretreated with 10
−8 M leptin and then ACh 
(10
−9 -10
−4 M) was administered to PE-induced precon-
tracted strips. Leptin significantly enhanced the ACh-in-
duced endothelium-dependent relaxation (n=12) (Fig. 2).
2. Mechanism of the relaxation response for leptin
To determine the mechanism involved in the responses in-
duced by pretreatment with 10
−8 M leptin, contraction in-
duced by high-concentration KCl solution (35, 70, 105, or 
140 mM) was assessed with or without leptin pretreatment. 
The KCl-induced contractile responses were significantly 
inhibited by leptin pretreatment (n=8) (Fig. 3). Verapamil- 
induced relaxation responses were enhanced by leptin with 
statistical significance (n=12) (Fig. 4). 
    L-NAME reversed the effect of leptin on enhancing 
ACh-induced relaxation, but there was no statistical differ-Korean J Urol 2011;52:136-141
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FIG. 5. Concentration-response curves for the effect of leptin pretreatment on ACh responses in cavernosal strips treated with 10
−5
M L-NAME (A) or 0.1 mM L-arginine (B). The preparation was preconstricted with 10
−5 M PE. n=12 in each. 
a: p＜0.05 compared with 
control, 
b: p＜0.01 compared with control.
FIG. 6. Concentration-response curves for the effects of pretreatment with L-NAME (A) or methylene blue (B) on rabbit clitoral corpus 
cavernosal strips with increasing leptin doses. The preparation was preconstricted with 70 mM KCl solution. n=8 in each; 
a: p＜0.05.
ence between L-NAME treatment and L-NAME plus leptin 
(n=12) (Fig. 5A). L-arginine (0.1 mM) enhanced the ACh- 
induced relaxation responses of leptin, and more potent re-
laxation responses appeared with combined arginine plus 
leptin treatment than with arginine single treatment 
(n=12) (Fig. 5B).
    To determine whether the relationship of inhibiting ef-
fects of leptin on KCl-induced contraction was an NO-medi-
ated mechanism, the effects of two inhibitors of the 
NOS-acting mechanism (L-NAME [10
−5  M] and the solu-
ble guanylate cyclase inhibitor methylene blue [10
−5  M]) 
were assessed with respect to dose-dependent effects of lep-
tin (10
−11-10
−7 M) on KCl-induced contraction. Following 
treatment with L-NAME and methylene blue, the inhibit-
ing effects of KCl-induced contraction were reversed (n=8 
in each) (Fig. 6). 
    Leptin did not affect the dose-dependent SNP-induced 
(10
−9-10
−4 M) relaxation responses. The enhancing effect 
of leptin on ACh-induced relaxation was not changed by 
treatment with indomethacin (a COX inhibitor, 10
−5  M) 
or the potassium channel blockers (n=8 in each) TEA (1 and 
10 mM), glibenclamide (10
−5  M), and 4-AP (10
−5  M) (data 
not shown).
DISCUSSION 
Contemporary research suggests that the adipocyte-derived 
hormone leptin may be an important factor linking obesity, 
metabolic syndrome, and cardiovascular disorders [14]. 
Leptin also acts on several peripheral tissues, including 
the vascular endothelium [15,16]. The leptin receptor has 
been identified in endothelial cells [17] and the action of 
leptin on the endothelium modulates several physiologic 
processes, with potential implications in pathophysio-
logical diseases associated with obesity [18]. In particular, 
leptin is involved in lipid metabolism and the functioning Korean J Urol 2011;52:136-141
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of vascular smooth muscle. It is known that leptin exerts 
vasopressor effects by activating the sympathetic nervous 
system. In contrast to its central neuronal sympathoexci-
tatory action, leptin has been shown to directly induce vaso-
relaxation via both NO-dependent and NO-independent 
mechanisms. Considering the pressor (sympathetic acti-
vation) and depressor (increased NO) actions, the in-
tegrated mechanism of actions of leptin on vascular tone 
and arterial blood pressure regulation is rather complex. 
Whereas the enhanced sympathetic nervous activation is 
expected to increase vascular tone and blood pressure, lep-
tin has been shown to elicit peripheral vascular relaxation 
mediated by NO-dependent or NO-independent mecha-
nisms in the absence of sympathetic control. Therefore, 
Ren suggested that leptin-induced peripheral NO release 
and vasorelaxation may serve to counterbalance the en-
hanced sympathetic activity in response to leptin [19].
    In the present study, ACh-induced relaxation responses 
were enhanced by leptin. This relaxation by leptin was re-
versed by L-NAME administration and was enhanced by 
a low dose of L-arginine (0.1 mM). Because ACh-induced 
relaxation is mediated in an endothelium-dependent man-
ner, these results suggest that endothelial integrity is crit-
ical for the vascular-relaxing action of leptin on the clitoral 
corpus cavernosum and is mediated via NOS activation. In 
addition, verapamil-induced relaxation responses were in-
creased and high-concentration KCl solution-induced con-
tractions were decreased by leptin. This inhibitory effect 
on KCl-induced contraction was reversed by methylene 
blue and L-NAME. Our findings suggest that leptin in-
hibits the voltage-dependent calcium channels indirectly 
by activating the NO-cGMP pathway.
    The effects of estrogen on increasing genital blood flow 
and smooth muscle relaxation have been attributed mostly 
to the regulation of eNOS [20]. It has been reported that 
the application of NO donor drugs, which are known to in-
crease tissue levels of cyclic GMP, may facilitate female 
genital vascular and nonvascular smooth muscle relaxa-
tion and thus sexual response [21]. Therefore, it is possible 
that the direct smooth muscle-relaxant effects of leptin 
may serve to counterbalance the enhanced sympathetic ac-
tivity as well as in blood vessels, preserving genital arousal 
in hyperleptinemia. 
    It has been reported that clitoral engorgement results 
from NO-initiated activation of BKCa channels (large-con-
ductance, calcium-activated potassium channels) [22]. 
Earlier studies on the corpus cavernosum of diabetic rab-
bits have also revealed that prostacyclin is an endothe-
lium-dependent relaxing factor [23]. However, the results 
of our study show that indomethacin, TEA, glibenclamide, 
and 4-AP did not affect leptin-induced relaxation effects. 
Therefore, we concluded that leptin-induced relaxant ef-
fects are not mediated by the cyclooxygenase pathway or 
various potassium channels.
    The proportion and effects of adipose tissue are greater 
in women than in men. This may be the reason for the gen-
der difference in the level and distribution of leptin se-
creted from adipocytes. Many studies have shown that the 
plasma leptin level is higher in females than in males, even 
when leptin is corrected for differences in body composition 
[24]. Rosenbaum et al suggested that this sexual di-
morphism is apparently also due, in part, to a suppressive 
effect of circulating androgens on leptin [25]. It has been 
reported that the mean serum leptin concentrations in 
obese subjects and normal-weight subjects are 10-55 ng/ml 
and 5-10 ng/ml, respectively, thus showing a strong pos-
itive correlation between serum leptin concentrations and 
the percentage of body fat [26]. In our study, we used a lep-
tin concentration of 10
−8 M, which is equivalent to 160 
ng/ml. Although this concentration is 3 to 5 times higher 
than that reported in obese people, in general, severely 
obese women may have a leptin serum concentration of this 
range considering that leptin levels are significantly high-
er in females than in males.
    To date, a functional leptin receptor has not been found 
in the clitoral or corporal cavernosum, but in vascular endo-
thelial cells. Therefore, further studies should investigate 
the possible presence of leptin receptors in the cavernosal 
endothelium. In addition, in vivo animal studies and clin-
ical studies on the effect of leptin on female sexuality in hy-
perleptinemia are required. 
CONCLUSIONS
Leptin in high concentrations may have an enhancing ef-
fect on rabbit clitoral corpus cavernosal smooth muscle 
relaxation. These processes may occur via clitoral endothe-
lium-dependent relaxation and voltage-dependent cal-
cium channel blockade. We suggest that endothelium-de-
pendent NO may have potential calcium channel blocking 
activity. Leptin may modulate the vasomotor action of the 
clitoris and serve to counterbalance enhanced sympathetic 
activity, thus preserving genital arousal in hyperleptinemia.
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